Association of Chronic Urticaria with Psychological Distress: A Multicentre Cross-sectional Study.


Journal

Acta dermato-venereologica
ISSN: 1651-2057
Titre abrégé: Acta Derm Venereol
Pays: Sweden
ID NLM: 0370310

Informations de publication

Date de publication:
14 Feb 2023
Historique:
received: 31 05 2022
accepted: 21 09 2022
pubmed: 22 9 2022
medline: 17 2 2023
entrez: 21 9 2022
Statut: epublish

Résumé

Chronic urticaria is a debilitating disease that affects health-related quality of life, but few studies have evaluated its impact on psychological wellbeing. The aim of this study was to evaluate the quality of life of patients with chronic urticaria and determine its impact on their emotional and psychological wellbeing. A cross-sectional multicentre study of a cluster of 264 Lebanese patients visiting dermatology/immunology clinics was conducted between July 2018 and June 2020. The impact of chronic urticaria on quality of life was assessed using the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) and Dermatology Life Quality Index (DLQI), as well as its consequences on mood changes using the Patient Health Questionnaire-9 (PHQ-9) and Beirut Distress Score 22 (BDS-22) scores. A multivariable analysis of covariates was performed to determine the effect of the triggering factors of urticaria on both CU-Q2oL and PHQ-9. A moderate negative correlation was found between Urticaria Control Test and quality of life scores as well as PHQ-9 and BDS-22 (p < 0.001). Patients with the lowest Urticaria Control Test score had the highest impairment in quality of life and depression scores. In conclusion, chronic urticaria compromises patients' quality of life and emotional wellbeing. This distress is more pronounced when the disease is more severe.

Identifiants

pubmed: 36129251
doi: 10.2340/actadv.v102.2939
pmc: PMC9940724
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

adv00865

Références

Allergy. 2003 Jul;58(7):621-3
pubmed: 12823121
J Investig Allergol Clin Immunol. 2011;21(2):93-100
pubmed: 21462798
Psychiatry Res. 2016 May 30;239:245-52
pubmed: 27031595
J Dermatol Sci. 2011 Apr;62(1):36-41
pubmed: 21333502
Allergy. 2009 Jun;64(6):927-36
pubmed: 19453340
Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):345-59
pubmed: 20633738
Asia Pac Allergy. 2015 Oct;5(4):197-202
pubmed: 26539401
Asia Pac Allergy. 2011 Apr;1(1):25-9
pubmed: 22053293
Psychother Psychosom. 1989;51(3):135-41
pubmed: 2636418
Allergol Int. 2010 Dec;59(4):345-54
pubmed: 20864795
J Eur Acad Dermatol Venereol. 2008 Jan;22(1):36-40
pubmed: 18181971
An Bras Dermatol. 2016 Nov-Dec;91(6):754-759
pubmed: 28099596
Allergy. 2011 Mar;66(3):317-30
pubmed: 21083565
Br J Dermatol. 2013 Oct;169(4):734-59
pubmed: 23679682
Clin Transl Allergy. 2019 Aug 23;9:42
pubmed: 31462988
Br J Dermatol. 2005 Feb;152(2):289-95
pubmed: 15727641
J Allergy Clin Immunol. 2014 May;133(5):1365-72, 1372.e1-6
pubmed: 24522090
J Investig Dermatol Symp Proc. 2004 Mar;9(2):169-80
pubmed: 15083785
Br J Dermatol. 2006 Feb;154(2):294-8
pubmed: 16433799
Clin Transl Allergy. 2015 Dec 02;5:40
pubmed: 26634118
Int J Dermatol. 2020 Aug;59(8):893-901
pubmed: 32638368
BMJ Open. 2015 Jan 14;5(1):e006450
pubmed: 25588781
Clin Exp Dermatol. 2010 Dec;35(8):869-73
pubmed: 20456386
Saudi Med J. 2017 Dec;38(12):1230-1236
pubmed: 29209673
Allergy. 2005 Aug;60(8):1073-8
pubmed: 15969690
Br J Dermatol. 2009 Mar;160(3):633-41
pubmed: 19014398
Br J Dermatol. 2002 Jun;146(6):1031-7
pubmed: 12072072
Allergy Asthma Proc. 2006 Mar-Apr;27(2):96-9
pubmed: 16724624
J Dermatol. 2018 Aug;45(8):963-970
pubmed: 29897137
Ann Allergy Asthma Immunol. 2004 Aug;93(2):142-6
pubmed: 15328673
Clin Exp Dermatol. 1994 May;19(3):210-6
pubmed: 8033378
J Investig Allergol Clin Immunol. 2009;19 Suppl 2:21-6
pubmed: 19530414
Patient. 2015 Dec;8(6):551-8
pubmed: 26476961
J Eur Acad Dermatol Venereol. 2018 Feb;32(2):282-290
pubmed: 28898460
Adv Ther. 2016 Feb;33(2):214-24
pubmed: 26833304
J Invest Dermatol. 2005 Nov;125(5):952-5
pubmed: 16297195
Br J Dermatol. 2008 Nov;159(5):997-1035
pubmed: 18795920
Allergy. 2019 Dec;74(12):2542-2544
pubmed: 31169906
Int J Behav Med. 2006;13(3):237-43
pubmed: 17078774
J Dermatol. 2014 Mar;41(3):200-4
pubmed: 24628069
Ann Allergy Asthma Immunol. 2007 Jul;99(1):29-33
pubmed: 17650826
Allergy. 2014 Jul;69(7):868-87
pubmed: 24785199
BMC Psychiatry. 2011 Apr 18;11:63
pubmed: 21501507
Br J Dermatol. 2016 Apr;174(4):892-4
pubmed: 26406483

Auteurs

Samah Tawil (S)

INSPECT-LB: Institut National de Santé Publique, Epidémiologie Clinique et Toxicologie, Beirut, Lebanon; Lebanese American University, School of medicine, Byblos, Lebanon, Beirut. samah.tawil@lau.edu.

Carla Irani (C)

Internal Medicine and Clinical Immunology, Hotel-Dieu de France Hospital, Saint Joseph University, Beirut.

Riwa Kfoury (R)

Faculty of Pharmacy and of Medical Sciences, Lebanese University, Hadath, Lebanon.

Soula Abramian (S)

Drug Information Center, Lebanese Order of Pharmacists, Beirut, Lebanon.

Pascale Salameh (P)

INSPECT-LB: Institut National de Santé Publique, Epidémiologie Clinique et Toxicologie, Beirut, Lebanon; Faculty of Pharmacy and of Medical Sciences, Lebanese University, Hadath, Lebanon; Faculty of Medical School, University of Nicosia, Nicosia, Cyprus.

Karsten Weller (K)

Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin, Berlin, Germany.

Marcus Maurer (M)

Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin, Berlin, Germany.

Khaled Ezzedine (K)

EA7379 Epiderm E (Epidemiology in Dermatology and Therapeutics Evaluation), UPEC-University, Paris-Est, Creteil, Creteil, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH